Scanadu

In mid 2011, Scanadu set up a lab at NASA Ames Research Center in Mountain View, California, to help grow the company.

[6] Scanadu was seeking approval by the U.S. Food and Drug Administration (FDA) for the device before bringing it to market to ensure clinical-grade accuracy.

[citation needed] It subsequently relaunched as inui Health, claiming "FDA clearance for its smartphone-enabled home urine testing platform.

The Scanadu Scout is a lightweight device that is touched to a patient's temple and is touted as being able to return key vital sign results in less than 10 seconds.

[13] Scanadu's long-term product vision is to combine a broad array of electrical and biochemical sensors with intelligent algorithms to create a real-life Tricorder.

[16] The idea is to help enable personalized medicine by generating collective information about the relationships between such readings as respiration, temperature and oxygen intake before the onset of a disease.

[16] The need for a product like the Scanadu Scout occurred to CEO Walter De Brouwer in 2003 after his five-year-old son[17] fell about 40 feet and lapsed into a coma for 11 weeks.

[9] The company includes team members specializing in the fields of design, hardware, software, algorithm development, regulatory, clinical testing, manufacturing, and in-vitro diagnostics.

[7] Also in November 2013, Scanadu announced it had formed a Medical Advisory Board and would conduct its first clinical trials at the Scripps Translational Science Institute.